Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT150 and Alcohol PK Interaction Study
NCT04331288Phase 1Completed
- Sponsor
- Pop Test Oncology LLC
- Start
- Nov 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ORG-34517 in alcohol use disorder (AUD), sponsored by Pop Test Oncology LLC. Primary endpoints: Difference in maximum concentration of PT150 at Day 9, Difference in time of maximum concentration of PT150 at Day 9 and 2 more. Started Nov 2021; status: completed.
02
Drugs
ORG-34517
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04331288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04331288.